Finnrick - Ensuring a Safer and More Transparent Supply Chain
LN Peptides

LN Peptides
Retatrutide

Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from LN Peptides between 17 Nov 2025 and 20 Feb 2026. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
B
GOOD
LN Peptides
Retatrutide
Tested 7 Samples
Last test 20 Feb 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from LN Peptides

Samples are tested in commercial labs

Tests Count

7

Scores

AVG6.7MIN5.0MAX8.0

Last

20 Feb 2026

First

17 Nov 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
20 Feb 2026View5.410mg11.3mg+13.0%99.70%(no batch ID)White Label / Silver Crimp / White CapLab GPublic
15 Feb 2026View7.830mg30mg99.80%(no batch ID)No Label / Silver Crimp / Clear Pink CapLab GPublic
11 Feb 2026View8.030mg29.7mg-1.0%99.90%(no batch ID)White Label / Silver Crimp / Clear Pink CapLab EPublic
15 Jan 2026View7.620mg21.1mg+5.5%99.80%(no batch ID)No Label / Silver Crimp / Clear Pink CapLab GPublic
15 Jan 2026View5.815mg16.8mg+12.0%99.80%(no batch ID)No Label / Black Crimp / Clear CapLab GPublic
5 Dec 2025View5.050mg42.1mg-15.8%99.70%(no batch ID)No Label / Silver Crimp / Clear Pink CapLab GPublic
17 Nov 2025View7.240mg37.7mg-5.8%99.68%(no batch ID)White Label / Silver Crimp / Clear Pink CapLab EPublic